$4.02
0.041.13%
Pre-Market: 7:01 AM EDT
Comments
Loading...
Biomea Fusion (BMEA) Forecast
NewsEarningsBiomea Fusion (BMEA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBiomea Fusion (NASDAQ:BMEA) Stock Quotes, Forecast and News Summary
Biomea Fusion Stock (NASDAQ: BMEA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Biomea Fusion (BMEA) stock?
You can purchase shares of Biomea Fusion (NASDAQ:BMEA) through any online brokerage.
Who are Biomea Fusion (BMEA) competitors?
Other companies in Biomea Fusion’s space includes: Innate Pharma (NASDAQ:IPHA), Cabaletta Bio (NASDAQ:CABA), Zentalis Pharma (NASDAQ:ZNTL), Adaptimmune Therapeutics (NASDAQ:ADAP) and Fate Therapeutics (NASDAQ:FATE).
What is the forecast, or price target, for Biomea Fusion (BMEA) stock?
Biomea Fusion has a consensus price target of $34.59.
What is the current price for Biomea Fusion (BMEA)?
The stock price for Biomea Fusion (NASDAQ: BMEA) is $4.02 last updated January 21, 2025 at 7:01 AM EST.
Does Biomea Fusion (BMEA) pay a dividend?
There are no upcoming dividends for Biomea Fusion.
When is Biomea Fusion (NASDAQ:BMEA) reporting earnings?
Biomea Fusion’s Q4 earnings are confirmed for Monday, March 31, 2025.
Is Biomea Fusion (BMEA) going to split?
There is no upcoming split for Biomea Fusion.
What sector and industry does Biomea Fusion (BMEA) operate in?
Biomea Fusion is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.